BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossi E, Zamarchi R. Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era? Front Genet 2019;10:958. [PMID: 31681412 DOI: 10.3389/fgene.2019.00958] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Xia F, Ma Y, Chen K, Duong B, Ahmed S, Atwal R, Philpott D, Ketela T, Pantea J, Lin S, Angers S, Kelley SO. Genome-wide in vivo screen of circulating tumor cells identifies SLIT2 as a regulator of metastasis. Sci Adv 2022;8:eabo7792. [PMID: 36054348 DOI: 10.1126/sciadv.abo7792] [Reference Citation Analysis]
2 Payne K, Brooks J, Batis N, Taylor G, Nankivell P, Mehanna H. Characterizing the epithelial-mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma. Head Neck 2022. [PMID: 35932094 DOI: 10.1002/hed.27167] [Reference Citation Analysis]
3 Gayan S, Joshi G, Dey T. Biomarkers of mitochondrial origin: a futuristic cancer diagnostic. Integr Biol (Camb) 2022:zyac008. [PMID: 35780307 DOI: 10.1093/intbio/zyac008] [Reference Citation Analysis]
4 Hakim M, Kermanshah L, Abouali H, Hashemi HM, Yari A, Khorasheh F, Alemzadeh I, Vossoughi M. Unraveling Cancer Metastatic Cascade Using Microfluidics-based Technologies. Biophys Rev. [DOI: 10.1007/s12551-022-00944-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kapeleris J, Ebrahimi Warkiani M, Kulasinghe A, Vela I, Kenny L, Ladwa R, O'Byrne K, Punyadeera C. Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer-An Update. Front Oncol 2022;12:859152. [PMID: 35372000 DOI: 10.3389/fonc.2022.859152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Papadaki MA, Agelaki S. Single-Cell RNA Sequencing Uncovers Heterogeneous Circulating Tumor Cell Subsets in Breast Cancer. Cancers 2022;14:1314. [DOI: 10.3390/cancers14051314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Radfar P, Aboulkheyr Es H, Salomon R, Kulasinghe A, Ramalingam N, Sarafraz-yazdi E, Thiery JP, Warkiani ME. Single-cell analysis of circulating tumour cells: enabling technologies and clinical applications. Trends in Biotechnology 2022. [DOI: 10.1016/j.tibtech.2022.02.004] [Reference Citation Analysis]
8 Shoji Y, Bustos MA, Gross R, Hoon DSB. Recent Developments of Circulating Tumor Cell Analysis for Monitoring Cutaneous Melanoma Patients. Cancers (Basel) 2022;14:859. [PMID: 35205608 DOI: 10.3390/cancers14040859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Nishida K, Sekida S, Anada T, Tanaka M. Modulation of Biological Responses of Tumor Cells Adhered to Poly(2-methoxyethyl acrylate) with Increasing Cell Viability under Serum-Free Conditions. ACS Biomater Sci Eng 2022. [PMID: 35037460 DOI: 10.1021/acsbiomaterials.1c01469] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Frenea-robin M, Marchalot J. Basic Principles and Recent Advances in Magnetic Cell Separation. Magnetochemistry 2022;8:11. [DOI: 10.3390/magnetochemistry8010011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
11 Chelakkot C, Yang H, Shin YK. Relevance of Circulating Tumor Cells as Predictive Markers for Cancer Incidence and Relapse. Pharmaceuticals 2022;15:75. [DOI: 10.3390/ph15010075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Payne K, Brooks JM, Taylor GS, Batis N, Noyvert B, Pan Y, Nankivell P, Mehanna H. Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery. Cancers (Basel) 2021;13:5519. [PMID: 34771681 DOI: 10.3390/cancers13215519] [Reference Citation Analysis]
13 Rossi T, Gallerani G, Martinelli G, Maltoni R, Fabbri F. Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue. Biomedicines 2021;9:1242. [PMID: 34572427 DOI: 10.3390/biomedicines9091242] [Reference Citation Analysis]
14 Dasari K, Somarelli JA, Kumar S, Townsend JP. The somatic molecular evolution of cancer: Mutation, selection, and epistasis. Prog Biophys Mol Biol 2021:S0079-6107(21)00096-1. [PMID: 34364910 DOI: 10.1016/j.pbiomolbio.2021.08.003] [Reference Citation Analysis]
15 Mehrmohamadi M, Sepehri MH, Nazer N, Norouzi MR. A Comparative Overview of Epigenomic Profiling Methods. Front Cell Dev Biol 2021;9:714687. [PMID: 34368164 DOI: 10.3389/fcell.2021.714687] [Reference Citation Analysis]
16 Lovero D, D'Oronzo S, Palmirotta R, Cafforio P, Brown J, Wood S, Porta C, Lauricella E, Coleman R, Silvestris F. Correlation between targeted RNAseq signature of breast cancer CTCs and onset of bone-only metastases. Br J Cancer 2021. [PMID: 34272498 DOI: 10.1038/s41416-021-01481-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Hu X, Zang X, Lv Y. Detection of circulating tumor cells: Advances and critical concerns. Oncol Lett 2021;21:422. [PMID: 33850563 DOI: 10.3892/ol.2021.12683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wu L, Wang Y, Xu X, Liu Y, Lin B, Zhang M, Zhang J, Wan S, Yang C, Tan W. Aptamer-Based Detection of Circulating Targets for Precision Medicine. Chem Rev 2021. [PMID: 33667075 DOI: 10.1021/acs.chemrev.0c01140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
19 Bocci F, Mandal S, Tejaswi T, Jolly MK. Investigating epithelial‐mesenchymal heterogeneity of tumors and circulating tumor cells with transcriptomic analysis and biophysical modeling. Comp Sys Onco 2021;1. [DOI: 10.1002/cso2.1015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
20 Singh B, Arora S, D'Souza A, Kale N, Aland G, Bharde A, Quadir M, Calderón M, Chaturvedi P, Khandare J. Chemo-specific designs for the enumeration of circulating tumor cells: advances in liquid biopsy. J Mater Chem B 2021;9:2946-78. [PMID: 33480960 DOI: 10.1039/d0tb02574g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zhu L, Kan KJ, Grün JL, Hissa B, Yang C, Győrffy B, Loges S, Reißfelder C, Schölch S. GAS2L1 Is a Potential Biomarker of Circulating Tumor Cells in Pancreatic Cancer. Cancers (Basel) 2020;12:E3774. [PMID: 33333841 DOI: 10.3390/cancers12123774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Li Z, Liu X, Zhang W, Zhuang X. Electrostatic reaction for the detection of circulating tumor cells as a potential diagnostic biomarker for metastasis in solid tumor. Nanotheranostics 2020;4:233-41. [PMID: 32923313 DOI: 10.7150/ntno.46928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Rossi T, Gallerani G, Angeli D, Cocchi C, Bandini E, Fici P, Gaudio M, Martinelli G, Rocca A, Maltoni R, Fabbri F. Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer. Cancers (Basel) 2020;12:E2490. [PMID: 32887501 DOI: 10.3390/cancers12092490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
24 Stepula E, Wang XP, Srivastav S, König M, Levermann J, Kasimir-Bauer S, Schlücker S. 6-Color/1-Target Immuno-SERS Microscopy on the Same Single Cancer Cell. ACS Appl Mater Interfaces 2020;12:32321-7. [PMID: 32573192 DOI: 10.1021/acsami.0c07269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Choi JR, Yong KW, Choi JY, Cowie AC. Single-Cell RNA Sequencing and Its Combination with Protein and DNA Analyses. Cells 2020;9:E1130. [PMID: 32375335 DOI: 10.3390/cells9051130] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
26 Song Y, Jia Z, Wang Y, Wang Y, Liu P, Zhang S, Bing Z, Cao L, Cao Z, Rossi E, Zamarchi R, Denis MG, Camps C, Fernandez-Diaz AB, Liang N, Li S. Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q. J Thorac Dis 2020;12:2771-80. [PMID: 32642185 DOI: 10.21037/jtd.2020.03.29] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]